Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Return on Equity (2016 - 2020)

Historic Return on Equity for Glucotrack (GCTK) over the last 6 years, with Q3 2020 value amounting to 0.41%.

  • Glucotrack's Return on Equity fell 39800.0% to 0.41% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.41%, marking a year-over-year decrease of 39800.0%. This contributed to the annual value of 1.64% for FY2019, which is 23100.0% down from last year.
  • Per Glucotrack's latest filing, its Return on Equity stood at 0.41% for Q3 2020, which was down 39800.0% from 0.38% recorded in Q2 2020.
  • In the past 5 years, Glucotrack's Return on Equity registered a high of 4.39% during Q3 2019, and its lowest value of 4.88% during Q4 2019.
  • Its 5-year average for Return on Equity is 0.12%, with a median of 0.29% in 2017.
  • Examining YoY changes over the last 5 years, Glucotrack's Return on Equity showed a top increase of 54100bps in 2019 and a maximum decrease of -51700bps in 2019.
  • Glucotrack's Return on Equity (Quarter) stood at 0.54% in 2016, then tumbled by -285bps to 1.0% in 2017, then skyrocketed by 129bps to 0.29% in 2018, then tumbled by -1795bps to 4.88% in 2019, then skyrocketed by 108bps to 0.41% in 2020.
  • Its Return on Equity stands at 0.41% for Q3 2020, versus 0.38% for Q2 2020 and 0.79% for Q1 2020.